Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition
Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition brings to 82 the number of centers operated by the company.
In other news, the company last month raised $26 million through an issue of senior notes to a group of insurance companies led by John Hancock Mutual Life Insurance. The Hackensack, NJ, company said it would use proceeds from the issue to fund acquisitions and for general corporate purposes. The placement brings the total amount that Medical Resources has raised this year through investment-grade senior note issues to $78 million.
In other Medical Resources news, the company acquired a controlling interest in a multimodality imaging center in midtown Manhattan. Medical Resources paid $1 million for the stake in the center, which is located within a state-of-the art medical suite to be opened by a private physician group this fall. The center is also the company's first joint venture with a physician practice management company.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.